Tacrolimus/cerivastatin interaction study in liver transplant recipients.
Mück
W
W
Neal
D A
DA
Boix
O
O
Voith
B
B
Hasan
R
R
Alexander
G J
GJ
D000214:Acyl Coenzyme A / Q000378:metabolism; D000328:Adult; D016572:Cyclosporine / Q000493:pharmacokinetics; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D005260:Female; D006084:Graft Rejection / Q000378:metabolism / Q000517:prevention & control; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000493:pharmacokinetics / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D011725:Pyridines / Q000493:pharmacokinetics* / Q000627:therapeutic use; D016559:Tacrolimus / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use
D000214:Acyl Coenzyme A; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007166:Immunosuppressive Agents; D011725:Pyridines; C008047:3-hydroxy-3-methylglutaryl-coenzyme A; D016572:Cyclosporine; D003577:Cytochrome P-450 Enzyme System; C086276:cerivastatin; D016559:Tacrolimus